key: cord-0900750-dyx60gbl
authors: Thiessen, Carrie; Wisel, Steven A.; Yamaguchi, Seiji; Dietch, Zachary C.; Feng, Sandy; Freise, Chris E.
title: Rapid Modification of Workflows and Fellow Staffing at a Single Transplant Center to Address the COVID-19 Crisis
date: 2020-05-12
journal: Transplant Proc
DOI: 10.1016/j.transproceed.2020.05.002
sha: d818156aa1d66f81eed346a53e7db4165925b49d
doc_id: 900750
cord_uid: dyx60gbl

Abstract Background Although hospital systems have largely halted elective surgical practices in preparing their response to the SARS-CoV-2 pandemic, transplantation remains an essential and lifesaving surgical practice. In order to continue transplantation while protecting immunocompromised patients and healthcare workers, significant restructuring of normal patient care practice habits is required. Methods This is a non-randomized, descriptive study of the abdominal transplant program at one academic center (University of California, San Francisco) and the programmatic changes undertaken to safely continue transplantations. Patient transfers, fellow utilization, and patient discharge education were identified as key areas requiring significant reorganization. Results The University of California, San Francisco abdominal transplant program took an early and aggressive approach to restructuring inpatient workflows and healthcare worker staffing. We formalized a COVID-19 transfer system to address patients in need of services at our institution while minimizing the risk of SARS-CoV-2 on our transplant ward and utilized technological approaches to provide virtual telehealth where possible, We also modified our transplant fellow staffing and responsibilities to develop an adequate backup system in the case of potential exposures. Conclusion Every transplant program is unique, and an individualized plan to adapt and modify standard clinical practices will be required to continue providing essential transplantation services. Our experience highlights areas of attention specific to transplant programs, and may provide generalizable solutions to support continued transplantation in the COVID-19 era.

April 2020, we have had no documented nosocomial transmissions in the UCSF system.

Here, we describe our center's approaches to three areas that may be of particular interest to the transplant community: management of transfers of patients, modifications to fellow training, and patient education. SARS-CoV-2 testing evolved during the period described. Through 16 April 2020 4023 tests were completed at UCSF, with 144 (3.5%) positive results. Initially, the hospital had limited capacity to run in-house RT-PCR assays, which required up to 24 hours for results. Overflow tests were sent to a nearby hospital with up to a 5-day turn-around time. This rendered it nearly impossible to obtain results in a timely fashion prior to a deceased donor transplant. Over the course of the next several weeks, testing capacity and speed improved significantly. At the time of writing, RT-PCR testing was performed on the ePlex system that required 2.5-3 hours per run. By mid-April, we were testing all potential recipients and donors and had developed a system to expedite processing pre-transplant. Our current policy is to screen all transplant recipients and living donors within 4 days of their operation. For recipients of deceased donor organs, we recommend early admission to provide additional time for COVID-19 testing while minimizing cold ischemia time.

This study was exempt from review by an Institutional Review Board or ethics panel.

Prior to COVID-19, there were an average of 17 transfers a month to the kidney service and 22 transfers a month to the liver service from outside facilities ( Figure 1 ). Our customary practice is to ask most patients with post-operative complications requiring inpatient care to come to UCSF, either via presentation to the ED, direct admission, or transfer from an outside hospital.

In addition, transfers to the liver service include patents with high Model of End-Stage Liver Disease (MELD) scores who are referred for expedited evaluation for liver transplantation.

Typically, transfers are approved by the on-service attending physician, then arranged through a transfer center that helps coordinate paperwork, bed management, and transportation. Patients are admitted to the multi-disciplinary transplant service housed within a single hospital unit.

UCSF began preparing for a surge in COVID admissions around the same time as the first COVID-19 positive patient was admitted on 3 February 2020. Shortly thereafter UCSF established a transfer manager, whose authorization was required for any transfer from another facility. UCSF also designated a separate unit for patients with COVID-19. Transfers are restricted to patients who urgently needed specialized care. As a result, beginning in February 2020 the number of transplant patients being transferred has decreased notably on the kidney service (6 a month) but remained stable on the liver service (18 a month) ( Figure 1 ). The exact reasons for this change are not clear, but we hypothesize that this difference is attributable to the fact that the post-operative kidney complications were more readily managed via telephone advice to outside facilities, whereas many post-operative liver complications required specialized interventional radiology or endoscopic interventions that could not be performed 

The UCSF Abdominal Transplant Fellowship has four surgical fellows, who alternate between liver transplant, kidney transplant, deceased donor organ recovery, and pediatric transplantation. Our adult liver and kidney programs operate at our main campus; pediatric transplantation is based at UCSF Benioff Children's Hospital (BCH), approximately 4 miles from the main campus. We participate in organ procurements in California, Nevada, New Mexico, and Arizona, with recent changes to organ allocation policy expanding our catchment to include Oregon and Idaho. We have a regional procurement center 40 miles from our main campus, and 26% of local donors are relocated to that site.

The geographic arrangement of our clinical assignments across multiple sites created a natural stratification of at-risk clinical exposures. All adult patients with concern for COVID-19 in the UCSF Health system were routed to our main campus. In addition, the majority of admissions to the adult kidney and liver services were undergoing COVID-19 rule out, raising our suspicion that our fellows on the primary kidney and liver services would be at highest risk for nosocomial exposures. The UCSF Mission Bay campus, which houses BCH, is a clinical site dedicated to pediatric, oncology, and obstetrics/gynecology specialty care. As such, the campus is without a primary medical inpatient service and adult emergency services, resulting in all patients suspicious for COVID-19 being routed to the main campus.

We sequestered our donor and pediatric fellows off the main campus to leave two of our four fellows as relatively "unexposed" backups and to decrease the possibility of cross-campus and cross-team contamination. Our pediatric transplant fellow only reported to BCH, where four pediatric patients were screened for COVID-19 and all tested negative. Our donor fellow remained off campus under California's "shelter-in-place" ordinance, with exception of participating in off-site organ procurements. They assisted in the main campus operating room as case volume required with section head approval for each case, and visits to the hospital were limited as much as possible.

Our organ procurement practices were adjusted on a precautionary basis to limit fellow exposure risk to COVID-19. All donors within our organ procurement organization (OPO) were screened for COVID-19. As an institution, we elected to generally defer on donor after cardiac death (DCD) organ donation at this time. We felt that the rapid nature of such procurements, often with extubation in the operating room, posed a higher and perhaps unreasonable risk of exposure. Furthermore, we ruled out donors with respiratory symptoms or ground-glass opacities on chest CT. Despite uniform donor testing, there is a false negative rate of 20-30% on COVID-19 assays 5 , so we declined donors with any symptoms consistent with COVID-19 infection. Even with these precautions, travel to and operating in another hospital increases the exposure risk. Beginning in mid-March, we elected to use local organ recovery whenever possible, a practice which is now recommended by the United Network for Organ Sharing (UNOS) effective 28 March 2020 6 . If local recovery was not available, we also utilized faculty without clinical responsibilities to minimize fellow exposures.

Like many institutions, we quickly identified our rounding process as our major risk for exposures to patients and staff. Our rounding procedures across all campuses were transitioned to virtual rounds on 16 March 2020, in accordance with the social distancing ordinance for the Bay Area. Traditionally, we conduct daily table and walk rounds as a multidisciplinary team including surgeons, hepatologists and nephrologists, pharmacists, social workers, nutritionists, physical therapists, case managers, and trainees. This rounding model was inconsistent with the need for social distancing, and these multidisciplinary rounds were drastically restructured using Zoom videoconferencing (San Jose, CA). Rounding via telemedicine has been previously described as an adjunct to rounds, such as wound rounds in burn patients or allowing families to participate in ICU rounds 7, 8 , but rarely as the primary mode of rounding 1,9 . Prior to rounds, patients are seen by the intern or nurse practitioner and the fellow responsible for their care.

Multidisciplinary rounds then proceed via Zoom videoconference, with participants logging in from separate locations. All patient findings are discussed to form preliminary plans. Attendings only then see patients to confirm daily plans while minimizing exposure risk. In our experience, much of our usual rounding process is verbal exchange of data and chart review, which have naturally transitioned to the virtual setting and eliminate unnecessary congregation in the hallways. In theory, walk rounds could be conducted by a single individual, accompanied by a videoconferencing console to allow others to participate virtually.

The transplant section adopted a zero-tolerance policy mandating that any personnel with a single upper respiratory illness symptom, fever, or gastrointestinal distress be tested for COVID-19 prior to resuming work. To date, two of our fellows and two on-service interns have been tested for COVID-19 for mild symptoms, and all have returned negative. They returned to clinical duties after 24 hours without symptoms. One attending developed COVID-19; his exposure was thought to be community-based.

Patient instruction surrounding transplant medication regimens is an essential part of the discharge process, one which typically takes place over several days during extended, face-to- Since implementing this patient education strategy, we have experienced two medicationrelated readmissions. While medication-related readmissions do occur during normal practice, it is unclear if virtual education contributed to these readmissions. One readmitted patient had low health literacy and was highly reliant on caretakers to ensure medication compliance. It is important to consider that family members and caretakers may be minimizing contact with patients in the early post-transplant period to prevent infection. Although intended to limit potential COVID-19 exposures, this may impair the direct, in-person support network needed by some transplant recipients.

Transplantation remains an essential service in the COVID-19 era, with the American College of Surgeons recommending continuation of life-saving transplants without postponement 12 .

However, significant modifications must be made to ensure the safety of transplant recipients and healthcare workers. With improved turn-around times for SARS-CoV-2 testing, we recommend screening for all donors and potential transplant recipients prior to surgery. While we have described several workflow modifications, the transplant community will have to continually evaluate best practices on a center, regional, and national level as the course of the pandemic evolves.

COVID-19): Cases in U

Coronavirus (COVID-19) Health Orders

Tracking Coronavirus in California

San Francisco Department of Public Health (SFDPH)

UCSF Infectious Disease Division Daily COVID-19 Digest

March 28 UNOS update on COVID-19: UNOS strongly encourages local recovery of organs

qs=0d8f6d229c18de8691bca8d95ce1f8122119b9b1af75caae2 807a667568d48237114edd35f4ea0e13cda5bf5068aedbe9af65335711385b2b2a59a9a82e85 74292ed14fbd0560bb8> Published 2020

Evaluation of Burn Rounds Using Telemedicine: Perspectives from Patients, Families, and Burn Center Staff

Perceptions of Family Participation in Intensive Care Unit Rounds and Telemedicine: A Qualitative Assessment

Research on Patient Satisfaction of Robotic Telerounding: A Pilot Study in a Korean Population

Randomized Controlled Trial of a Computer-Based Education Program in the Home for Solid Organ Transplant Recipients: Impact on Medication Knowledge, Satisfaction, and Adherence

Using technology to enhance medication regimen education after solid organ transplantation

COVID-19: Guidance for Triage of Non-Emergent Surgical Procedures

The authors wish to thank John Hillman for providing data on patient transfers. Deborah Adey, Danielle Krieger, Claudia Praglin, and Giulia Worner also contributed background information relevant to the manuscript.

Background: Although hospital systems have largely halted elective surgical practices in preparing their response to the SARS-CoV-2 pandemic, transplantation remains an essential and lifesaving surgical practice. In order to continue transplantation while protecting immunocompromised patients and healthcare workers, significant restructuring of normal patient care practice habits is required.Methods: This is a non-randomized, descriptive study of the abdominal transplant program at one academic center (University of California, San Francisco) and the programmatic changes undertaken to safely continue transplantations. Patient transfers, fellow utilization, and patient discharge education were identified as key areas requiring significant reorganization.

The University of California, San Francisco abdominal transplant program took an early and aggressive approach to restructuring inpatient workflows and healthcare worker staffing. We formalized a COVID-19 transfer system to address patients in need of services at our institution while minimizing the risk of SARS-CoV-2 on our transplant ward and utilized technological approaches to provide virtual telehealth where possible, We also modified our transplant fellow staffing and responsibilities to develop an adequate backup system in the case of potential exposures.

Every transplant program is unique, and an individualized plan to adapt and modify standard clinical practices will be required to continue providing essential transplantation services. Our experience highlights areas of attention specific to transplant programs, and may provide generalizable solutions to support continued transplantation in the COVID-19 era.